對于慢性支氣管炎、肺氣腫和支氣管哮喘三環圖的一些困惑_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 何權瀛

北京大學人民醫院呼吸科（北京 100044）;

Corresponding?author：

何權瀛, Email: hxk313@126.com

Keywords：

DOI：

10.7507/1671-6205.202407129

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 何權瀛. 對于慢性支氣管炎、肺氣腫和支氣管哮喘三環圖的一些困惑. Chinese Journal of Respiratory and Critical Care Medicine, 2024, 23(8): 533-536. doi: 10.7507/1671-6205.202407129 Copy

1.	American Thracic Spiety. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Msd, 1995, 152(5pt2): s77-121.
2.	何權瀛. 支氣管哮喘何權瀛2020何權瀛觀點, 科學技術文獻出版社, 北京, 2021: 78-91.
3.	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2023GOLD Reports.,.
4.	Jeffery PK . Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med, 2001, 164, (10 pat2): s28-38.
5.	何權瀛. 25年來國內支氣管哮喘動物實驗研究中存在的幾個問題. 中華結核和呼吸雜志, 2021, 44(2): 110-114.
6.	Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assesment and identification using induced sputum. Respirology, 2006, 11(1): 54-61.
7.	Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol, 2013, 131(3): 636-645.
8.	Chung KF. Neutrophilic asthma : a distinct target for treatment . Lancet Respir Med, 2016, 4(10): 765-767.
9.	張永明, 林江濤, 蘇楠, 等. 支氣管哮喘患者氣道炎癥表型研究. 中華結核和呼吸雜志, 2015, 38(5): 348-351.
10.	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2024 GOLD Reports.
11.	中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. 慢性阻塞性肺疾病診治指南(2013年修訂版), 中華結核和呼吸雜志, 2013, 36(4): 255-264.
12.	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2022 GOLD Reports.
13.	中華醫學會呼吸系病分會哮喘學組. 支氣管哮喘的定義、診斷嚴重度分級及療效判斷標準(修正方案). 中華結核和呼吸雜志, 1993, 16: 5-10.
14.	中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(支氣管哮喘的定義、診斷、治療及管理方案). 中華結核和呼吸雜志, 2008, 31(3): 177-185.
15.	何權瀛. 執行慢性阻塞性肺疾病診治指南中的一點困惑. 中華結核和呼吸雜志, 2005, 28(5): 358.
16.	Global Initiative for Asthma. Global Strategy for Asrhma Management and Prevention 2014.
17.	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2014 GOLD Reports.
18.	Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2019 GOLD Reports.

1. American Thracic Spiety. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Msd, 1995, 152(5pt2): s77-121.
2. 何權瀛. 支氣管哮喘何權瀛2020何權瀛觀點, 科學技術文獻出版社, 北京, 2021: 78-91.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2023GOLD Reports.,.
4. Jeffery PK . Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med, 2001, 164, (10 pat2): s28-38.
5. 何權瀛. 25年來國內支氣管哮喘動物實驗研究中存在的幾個問題. 中華結核和呼吸雜志, 2021, 44(2): 110-114.
6. Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assesment and identification using induced sputum. Respirology, 2006, 11(1): 54-61.
7. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol, 2013, 131(3): 636-645.
8. Chung KF. Neutrophilic asthma : a distinct target for treatment . Lancet Respir Med, 2016, 4(10): 765-767.
9. 張永明, 林江濤, 蘇楠, 等. 支氣管哮喘患者氣道炎癥表型研究. 中華結核和呼吸雜志, 2015, 38(5): 348-351.
10. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2024 GOLD Reports.
11. 中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. 慢性阻塞性肺疾病診治指南(2013年修訂版), 中華結核和呼吸雜志, 2013, 36(4): 255-264.
12. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2022 GOLD Reports.
13. 中華醫學會呼吸系病分會哮喘學組. 支氣管哮喘的定義、診斷嚴重度分級及療效判斷標準(修正方案). 中華結核和呼吸雜志, 1993, 16: 5-10.
14. 中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(支氣管哮喘的定義、診斷、治療及管理方案). 中華結核和呼吸雜志, 2008, 31(3): 177-185.
15. 何權瀛. 執行慢性阻塞性肺疾病診治指南中的一點困惑. 中華結核和呼吸雜志, 2005, 28(5): 358.
16. Global Initiative for Asthma. Global Strategy for Asrhma Management and Prevention 2014.
17. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2014 GOLD Reports.
18. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. https://goldcopd.org/2019 GOLD Reports.

Next Article
Expression and significance of ZFP36/ZFP36L1 in peripheral blood of Patients with chronic obstructive pulmonary disease

Chinese Journal of Respiratory and Critical Care Medicine

對于慢性支氣管炎、肺氣腫和支氣管哮喘三環圖的一些困惑

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content